Trial Profile
Early effects of oral administrations of lafutidine with mosapride on intragastric pH
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Lafutidine (Primary) ; Mosapride (Primary)
- Indications Gastro-oesophageal reflux; Gastrointestinal ulcer; Peptic ulcer
- Focus Pharmacodynamics
- 12 Aug 2009 Status changed from not yet recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 12 Aug 2009 Actual initiation date (Sep 2008) added as reported by University Hospital Medical Information Network - Japan record.
- 18 Aug 2008 New trial record.